Abstract：
BACKGROUND: As members of a medical team, pharmacists are expected to provide optimal patient-centered, evidence-based pharmacotherapy. In Japan, in consideration of the importance of palliative care, a system was initiated for certifying palliative care pharmacists in 2010. However, no studies have evaluated the usefulness of board certification in palliative pharmacy. Therefore, we surveyed the status of medication guidance for the physical and psychological symptoms of patients receiving palliative care and compared the medication guidance provided by certified and uncertified pharmacists.
METHODS: The survey was conducted in February and March 2022. Pharmacists registered as members of the Japanese Society of Pharmaceutical Palliative Care and Sciences were surveyed by using a web-based questionnaire and 209 pharmacists responded: the certified pharmacist group comprised 123 (58.9%) pharmacists and the uncertified pharmacist group comprised 86 (41.1%) pharmacists.
RESULTS: The certified pharmacist group provided better and more frequent medication guidance, according to responses to four of the six items related to pain relief. Three items were related to non-pain symptom relief, and one of the four items was related to psychiatric symptom relief (P < 0.05). The study showed that the certified pharmacist group received a better rating than the uncertified pharmacist group for involvement in palliative pharmacotherapy leading to improvement of patient quality of life (P < 0.05).
CONCLUSIONS: As compared with uncertified pharmacists, certified pharmacists intervened more proactively and provided a broader range of palliative care.
METHODS: The survey was conducted in February and March 2022. Pharmacists registered as members of the Japanese Society of Pharmaceutical Palliative Care and Sciences were surveyed by using a web-based questionnaire and 209 pharmacists responded: the certified pharmacist group comprised 123 (58.9%) pharmacists and the uncertified pharmacist group comprised 86 (41.1%) pharmacists.
RESULTS: The certified pharmacist group provided better and more frequent medication guidance, according to responses to four of the six items related to pain relief. Three items were related to non-pain symptom relief, and one of the four items was related to psychiatric symptom relief (P < 0.05). The study showed that the certified pharmacist group received a better rating than the uncertified pharmacist group for involvement in palliative pharmacotherapy leading to improvement of patient quality of life (P < 0.05).
CONCLUSIONS: As compared with uncertified pharmacists, certified pharmacists intervened more proactively and provided a broader range of palliative care.
摘要：
背景：作为医疗团队的成员，预计药剂师将提供最佳的以患者为中心，循证药物治疗。在日本,考虑到姑息治疗的重要性，2010年启动了一个姑息治疗药剂师认证系统.然而,尚无研究评估委员会认证在姑息性药房中的有用性.因此,我们调查了接受姑息治疗的患者的生理和心理症状的用药指导情况,并比较了经认证和未经认证的药剂师提供的用药指导.
方法：调查于2022年2月和3月进行。通过使用基于网络的问卷对注册为日本药物姑息治疗和科学学会会员的药剂师进行了调查，209名药剂师做出了回应：经过认证的药剂师组包括123名（58.9％）药剂师，未经认证的药剂师组包括86名（41.1％）药剂师。
结果：认证的药剂师小组提供了更好，更频繁的用药指导，根据对与缓解疼痛有关的六个项目中的四个的回应。三项与非疼痛症状缓解有关，其中一项与精神症状缓解有关(P<0.05)。研究表明，与未认证的药剂师组相比，认证的药剂师组参与姑息性药物治疗可改善患者的生活质量（P<0.05）。
结论：与未经认证的药剂师相比，经过认证的药剂师进行了更积极的干预，并提供了更广泛的姑息治疗。
方法：调查于2022年2月和3月进行。通过使用基于网络的问卷对注册为日本药物姑息治疗和科学学会会员的药剂师进行了调查，209名药剂师做出了回应：经过认证的药剂师组包括123名（58.9％）药剂师，未经认证的药剂师组包括86名（41.1％）药剂师。
结果：认证的药剂师小组提供了更好，更频繁的用药指导，根据对与缓解疼痛有关的六个项目中的四个的回应。三项与非疼痛症状缓解有关，其中一项与精神症状缓解有关(P<0.05)。研究表明，与未认证的药剂师组相比，认证的药剂师组参与姑息性药物治疗可改善患者的生活质量（P<0.05）。
结论：与未经认证的药剂师相比，经过认证的药剂师进行了更积极的干预，并提供了更广泛的姑息治疗。
